IL17A and myeloid sarcoma: Serum IL-17 concentrations in untreated and treated MS patients: The mean serum IL-17 concentrations in newly diagnosed MS patients was significantly higher than healthy individuals and treated MS patients (P < 0.001 and P < 0.010, respectively) (Table 2) (Figure 2).